Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physician-induced torsade de pointes--therapeutic implications.

Wilhelm Haverkamp1, Gerold Mönnig, Eric Schulze-Bahr

  • 1Department of Cardiology and Angiology, Hospital of the University of Münster, and Institute for Arteriosclerosis Research at the University of Münster, Münster, Germany. haverkw@uni-muenster.de

Cardiovascular Drugs and Therapy
|July 2, 2002
PubMed
Summary

Torsade de pointes (TdP) is a dangerous heart rhythm linked to a prolonged QT interval. Understanding acquired TdP, often drug-induced, is crucial for prevention and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polygenic risk modulates myocardial repolarization and T-wave geometry in congenital long-QT syndrome type 1: evidence from digital ECG phenotyping.

Frontiers in cardiovascular medicine·2026
Same author

Clinical Profile and Mode of Initiation of Spontaneous Ventricular Tachyarrhythmias in Patients With Brugada Syndrome (START-BrS).

JACC. Clinical electrophysiology·2026
Same author

A MATLAB Algorithm to Automatically Estimate the QT Interval and Other ECG Parameters and Validation Using a Machine Learning Approach in Congenital Long-QT Syndrome.

Journal of cardiovascular translational research·2025
Same author

Durable effectiveness and safety of hybrid ablation versus catheter ablation: 2-year results from the randomized CEASE-AF trial†.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence complex diseases of the heart.

European heart journal. Quality of care & clinical outcomes·2025
Same author

Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort.

European heart journal·2025

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Torsade de pointes (TdP) is a serious ventricular tachyarrhythmia associated with a prolonged QT interval.
  • It can be congenital (long QT syndrome) or acquired, with acquired TdP mechanisms poorly understood.
  • Acquired TdP is frequently iatrogenic, often caused by drugs that prolong myocardial repolarization.

Purpose of the Study:

  • To elucidate the mechanisms of acquired long QT syndrome.
  • To highlight the clinico-electrocardiographic characteristics of drug-induced TdP.
  • To emphasize the need for risk factor identification and drug torsadogenicity quantification.

Main Methods:

  • Review of existing literature on TdP, congenital and acquired long QT syndrome.
  • Analysis of clinical and electrocardiographic features of drug-induced TdP.

Related Experiment Videos

  • Discussion of genetic factors and drug-induced repolarization abnormalities.
  • Main Results:

    • Congenital long QT syndrome is an ion channelopathy.
    • Mechanisms of acquired TdP remain largely unclear, with limited evidence of underlying genetic mutations.
    • Drug-induced TdP is a significant iatrogenic concern.

    Conclusions:

    • Physicians must recognize drug-induced TdP characteristics for diagnosis and management.
    • Preventing TdP requires identifying predisposing risk factors and quantifying drug torsadogenic potential.
    • Further research is needed to understand acquired TdP mechanisms and minimize drug-related risks.